Home Cholesterol Monitors — CPB 0367 | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0367 governing home cholesterol monitor coverage, with an effective date of 2025-09-26. Here's what billing teams need to know about HCPCS code A9279 and the 39 ICD-10 diagnosis codes that determine coverage.

Aetna's home cholesterol monitor coverage policy under CPB 0367 Aetna system has been updated as of September 26, 2025. The policy covers home cholesterol monitors billed under HCPCS A9279, with coverage tied to a specific set of lipid metabolism and lipoid disorder diagnoses spanning E71, E75, E77, E78, and E88 code families, plus Z13.220 for lipoid disorder screening encounters. If your practice or DME supplier bills A9279 for Aetna members, this update directly affects which claims will pay and which will not.

Quick-Reference Table

Aetna Home Cholesterol Monitor Coverage Criteria and Medical Necessity Requirements 2025

The core of Aetna's home cholesterol monitor coverage policy is diagnosis-driven. Aetna will not cover A9279 without a supporting ICD-10 code that maps to a recognized lipid or lipoid metabolism disorder. That's the first place denials happen — someone submits A9279 with a generic hyperlipidemia code that isn't on Aetna's list.

The covered diagnoses fall into four main families. Disorders of lipoid metabolism under E71.30, the E75 family (including E75.21, E75.22, and the full E75.24x range through E75.249), the E77 series (E77.0 through E77.9), and the E78 series (E78.0 through E78.9). E88.1, E88.2, and E88.89 round out the metabolic disorder codes. Z13.220 — the encounter code for lipoid disorder screening — is also on the covered list.

Medical necessity here means the patient has a documented lipid or lipoid metabolism condition, not just elevated cholesterol on a routine lab. The distinction matters. A member with a diagnosis of pure hypercholesterolemia (E78.0) is on the covered list. A member who simply had a high LDL on their last visit may not produce a qualifying ICD-10 if the diagnosing provider didn't code the encounter correctly.

The policy applies to home use. This is durable medical equipment territory — your billing team is submitting A9279 as a DME benefit, not a professional or technical component under a physician fee schedule. If your practice is billing A9279 directly rather than routing it through a DME supplier, confirm your Aetna contract covers that pathway before the effective date creates a denial pattern.

Prior authorization requirements for A9279 under CPB 0367 are not explicitly detailed in the current policy summary. That said, home monitoring devices that fall under DME benefits frequently require prior auth under Aetna plans. Verify prior authorization requirements for A9279 with Aetna's provider portal or your Aetna provider relations contact before submitting claims dated September 26, 2025 or later.

Aetna Home Cholesterol Monitor Exclusions and Non-Covered Indications

The policy data doesn't enumerate a specific exclusions list with separate codes. But the coverage structure is effectively an inclusion list — if the diagnosis code isn't on the 39-code ICD-10 list, the claim is not covered.

That's a practical exclusion. General dyslipidemia management with non-specific or unlisted codes won't meet medical necessity under this policy. Molecularly imprinted membrane monitors and stand-alone or integrated monitoring devices all fall under A9279, but the diagnosis documentation has to hold up.

If you're billing for patients with secondary hyperlipidemia caused by another condition — diabetes, hypothyroidism, renal disease — check whether the primary condition produces a covered ICD-10. The patient may carry a qualifying E78.x code alongside their primary diagnosis. If they don't, the claim will likely deny.

Coverage Indications at a Glance

Aetna Home Cholesterol Monitor Billing Guidelines and Action Items 2025

Home cholesterol monitor billing under CPB 0367 is straightforward if your documentation supports the diagnosis. Here's what to do before and after the September 26, 2025 effective date.

CPT, HCPCS, and ICD-10 Codes for Home Cholesterol Monitors Under CPB 0367

Covered HCPCS Codes (When Selection Criteria Are Met)

Key ICD-10-CM Diagnosis Codes

One thing to flag: the ICD-10 descriptions in the source policy data all read as "Disorders of lipoid metabolism" across the full E75, E77, E78, and E88 ranges. That's a data presentation issue on Aetna's end — the actual ICD-10-CM codes carry specific descriptions (E78.0 is pure hypercholesterolemia, E78.2 is mixed hyperlipidemia, and so on). Code your claims to the specific ICD-10 description, not the umbrella group label. If you're not sure which subcode applies to a specific patient, talk to your compliance officer before the effective date of September 26, 2025.